Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel treatments for urological disorders reported in recent Astellas and Mitsubishi Tanabe patents

Dec. 5, 2007

Nymox reports positive results from clinical study of NX-1207

Dec. 3, 2007

Plethora reports positive preliminary results from phase II study of PSD-503

Dec. 3, 2007

Ardana reports positive preliminary results from phase II study of teverelix LA

Nov. 27, 2007

Cytochroma initiates phase I/II clinical trial of CTAP-101 capsules

Nov. 22, 2007

Recent Novartis patent discloses novel agents for renal failure

Nov. 21, 2007

Quark initiates phase I clinical trial of AKIi-5 for acute renal failure

Nov. 21, 2007

Nymox completes 2-year follow-up study of NX-1207 for benign prostatic hyperplasia

Nov. 20, 2007

Vasohibin beneficial in early diabetic nephropathy model

Nov. 20, 2007

Prolonged renal effects seen with AlbuBNP in dogs

Nov. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...